LUCADA Jacqueline Brown Cancer Services Manager North Tees & Hartlepool Trust

Background 93% of expected new lung cancers have been recorded on LUCADA for the last report – over 38,000 cases Starting to produce some valuable information Some reports and data sources are using older data

Audit LUCADA Annual Report –Discussion at MDT –Mesothelioma patients –Surgical Resection Rates –Small Cell Chemotherapy –Data completeness

What can you get out of LUCADA Survival –LUCADA data goes back to years of 1 year and 6 month survival 3 years of 5 year survival

One Year Survival

Comparisons 8.1 Diagnostic and Staging Investigations Total number of patients registered 180 No. Patients (RVWAE)(RVWAE)(ALL_ORGS) CT scan % 83.8% PET or PET/CT Scan7441.1% 23.4% Bronchoscopy5731.7% 34.6% Diagnostic Biopsy5731.7% 18.1% CT Guided Biopsy3921.7% 17.5%

Comparisons 2.2 Time to first appointment from first referral to specialist team Total number of patients registered170 No. Patients RVWAEALL_ORGS Time to first appointment 6.0 Days 7.0 Days 2.3 Time to diagnosis from first referral to specialist team Total number of patients registered 170 No. PatientsRVWAEALL_ORGS Time to diagnosis 14.0 Days 20.0 Days

LUCADA Data Packs Information on your Trust Information on Network – can compare where you stand against different Trusts Ranks your Trust nationally –2.07 – Percentage receiving surgery all cases –The percentage of all lung cancers patients including mesothelioma cases recorded as receiving surgery as treatment –National ranking for RVW - North Tees and Hartlepool NHS Trust: 41 of 167

PS & Stage completeness (percentage) The percentage of cases where both the performance status and staging fields have been completed Data Last Refreshed: 22 December 2011 Available Data: 2007, 2008 and 2009 Next Data Update: December 2011 Source: National Lung Cancer Audit

PS & Stage completeness (percentage) The percentage of cases where both the performance status and staging fields have been completed Source: National Lung Cancer Audit

Make a note For the future –It is anticipated that data on co-morbidities will be included in future case-mix adjustments –It is anticipated that date on Lung Function Tests – FEV1 absolute and percentage will be included in future case mix adjustments

Useful Places

European Study ERS taskforce for Quality Management in Lung Cancer Care To assess the feasibility of collecting prospective data on lung cancer patients in multiple European countries Use data collected routinely via the National Lung Cancer Audit Patients diagnosed between the 1st and 31st May 2012 could be uploaded onto the NLCA system by the end of June 2012

Thank you